- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
American adults are wary of pharmaceutical company messaging
KFF poll finds credibility gap between drug-makers and consumers.
Credibility and cost may be two reasons why your patients aren’t taking their prescription medications.
“KFF Health Tracking Poll 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs,” focused partly on the emerging trend of pharmaceuticals used to treat type 2 diabetes and expanding to the weight loss industry treating people for overweight and obesity.
KFF also asked respondents about larger issues affecting the contemporary American pharmaceutical market. Among the findings: Americans don’t entirely trust medicine-makers and a growing number of patients think there’s not enough regulation on prescription drug prices.
Here’s what else KFF found.
